The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux.
about
Reflux revisited: advancing the role of pepsinCough: an unmet clinical need.Evaluation of an Innovative Over-the-Counter Treatment for Symptoms of Reflux Disease: Quick-Dissolving Alginate Granules.TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial.Management of globus pharyngeusOptimal treatment of laryngopharyngeal reflux disease.Ear, nose, and throat manifestations during pregnancy.Chronic cough, reflux, postnasal drip syndrome, and the otolaryngologist.12-minute consultation: an evidence-based approach to the management of dysphagia.Upper esophageal sphincter dysfunction: diverticula-globus pharyngeus.Alginate drug delivery systems: application in context of pharmaceutical and biomedical research.Unmet needs in treating laryngo-pharyngeal reflux disease: where do we go from here?The prevalence of laryngopharyngeal reflux in the English population.Adjuvant use of liquid alginate suspension for post-tonsillectomy morbidity: double-blind randomized clinical trial of efficacy.Rethinking the laryngopharyngeal reflux treatment algorithm: Evaluating an alternate empiric dosing regimen and considering up-front, pH-impedance, and manometry testing to minimize cost in treating suspect laryngopharyngeal reflux disease.Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.Extra-oesophageal reflux: state of the knowledge base.
P2860
Q21285006-3AFA0762-D2F6-479B-BD3B-C1C520FB7A17Q24604012-F627E5BD-99AD-4AE1-A9C8-0D248E567613Q36520044-49ED23A2-90AF-427C-BB97-BCCFE7914693Q36758465-82F9BBB7-80D5-47F5-BAEB-B18DDB2FB9E8Q37051999-43C074C1-BC78-4423-B990-1492511C0CD3Q37253915-21666289-1A93-4092-9F13-85ADF7D602DFQ37873692-7FABF973-6B83-484A-8A96-147900F6DA6BQ38009310-3F077F47-CAA3-48FE-B1F7-9FEB53B6CDDAQ38112705-F3C1637E-1343-4344-85C7-D95F2DA58091Q38151819-CD59EB71-ADDF-4BFC-82E5-9FC04CE2F534Q38238527-897EB5FF-9309-4A67-B015-0CDC3933CB53Q38823383-138189F9-5F28-4196-BCFB-87348AF7941CQ39248017-38DBD2B5-A0B0-49CC-8289-7005455E2C63Q46037436-5B9F2DA2-8AF9-4457-9CF5-13466C9B7CDDQ47712850-C6E49CD2-C3A9-4D16-8929-548717FD0BA3Q50129556-10E06CEC-1F15-4AFD-A16C-A1BE4A1F0BD2Q51398219-AFB2DEB8-6766-49D7-8613-86BC48BF41C9
P2860
The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The value of a liquid alginate ...... t of laryngopharyngeal reflux.
@en
The value of a liquid alginate suspension
@nl
type
label
The value of a liquid alginate ...... t of laryngopharyngeal reflux.
@en
The value of a liquid alginate suspension
@nl
prefLabel
The value of a liquid alginate ...... t of laryngopharyngeal reflux.
@en
The value of a liquid alginate suspension
@nl
P2093
P1476
The value of a liquid alginate ...... t of laryngopharyngeal reflux.
@en
P2093
John Sykes
Julian A McGlashan
Lesley M Johnstone
Peter W Dettmar
Vicki Strugala
P2888
P304
P356
10.1007/S00405-008-0708-7
P577
2008-05-28T00:00:00Z